Orchestra BioMed Holdings (OBIO) Inventory (2022 - 2026)
Orchestra BioMed Holdings (OBIO) reported Inventory of $277000.0 for Q1 2026, up 105.19% year-over-year from $135000.0 in Q1 2025, and down 10.65% on a QoQ basis from $310000.0 in Q4 2025.
Orchestra BioMed Holdings (OBIO) has 5 years of Inventory data on file, last reported at $277000.0 in Q1 2026.
- Quarterly Inventory rose 105.19% year-over-year to $277000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $277000.0 (up 105.19% YoY) and the FY2025 annual result came in at $310000.0, up 79.19% from the prior year.
- Inventory fell to $277000.0 in Q1 2026 per OBIO's latest filing, from $310000.0 in the prior quarter.
- Across five years, Inventory topped out at $365000.0 in Q3 2025 and bottomed at $70000.0 in Q2 2024.
- The 5-year median for Inventory is $181500.0 (2023), against an average of $202357.1.
- The widest annual swing landed in 2024, when Inventory tumbled 60.67%; it then surged 164.29% in 2025.
- Tracing OBIO's Inventory over 5 years: stood at $276000.0 in 2022, then sank by 47.1% to $146000.0 in 2023, then grew by 18.49% to $173000.0 in 2024, then soared by 79.19% to $310000.0 in 2025, then dropped by 10.65% to $277000.0 in 2026.
- Per Business Quant, the three latest OBIO Inventory figures stand at $277000.0 (Q1 2026), $310000.0 (Q4 2025), and $365000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Orchestra BioMed Holdings | 245.24 Mn | 255.02 Mn | 78,000.00 | 277,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 277,000.00 |
| Dec 31, 2025 | 310,000.00 |
| Sep 30, 2025 | 365,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Mar 31, 2025 | 135,000.00 |
| Dec 31, 2024 | 173,000.00 |
| Sep 30, 2024 | 234,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Dec 31, 2023 | 146,000.00 |
| Sep 30, 2023 | 137,000.00 |
| Jun 30, 2023 | 178,000.00 |
| Mar 31, 2023 | 232,000.00 |
| Dec 31, 2022 | 276,000.00 |